EGFR and neoplasm: LINC00969-mediated regulation of TKI resistance could enrich the knowledge of tumour resistance, and LINC00969 has great prospects as be a prognostic indicator and a potential therapeutic target for overcoming EGFR-TKI resistance in NSCLC (Fig. 8E).